Late development of intraventricular papillary pituitary carcinoma after irradiation of prolactinoma

Surg Neurol. 2006 Nov;66(5):527-33; discussion 533. doi: 10.1016/j.surneu.2006.02.039. Epub 2006 Jul 21.

Abstract

Background: Intracranial dissemination of pituitary adenomas is a rare event that does not equate malignancy. Most of the cases have been reported as metastases from pituitary carcinoma. A case of papillary pituitary carcinoma developed 12 years after radiotherapy for prolactin-secreting hormone pituitary adenoma is presented.

Case description: A 37-year-old woman was admitted for the second time with neurologic disturbance and hypertension. A gadolinium-enhanced magnetic resonance scan of the brain demonstrated a 50-mm enhanced mass (absent on previous studies) on the lateral ventricle, involving the left temporal lobe. The patient underwent a craniotomy and biopsy of the lesion that was consistent with pituitary carcinoma; it was immunoreactive to follicle-stimulating hormone, adrenocorticotropic hormone, pituitary tumor-transforming gene, and epithelial cell adhesion molecule. Transmission electron microscopy analysis confirmed the secretory pituitary tumor diagnosis.

Conclusions: The tumor was considered a primary pituitary papillary carcinoma. The clinical course indicated that this tumor was the seedling of a pituitary tumor, although it could be interpreted as metastases from a pituitary carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Papillary / diagnosis*
  • Carcinoma, Papillary / etiology
  • Carcinoma, Papillary / therapy
  • Cerebral Ventricle Neoplasms / diagnosis*
  • Cerebral Ventricle Neoplasms / etiology
  • Cerebral Ventricle Neoplasms / therapy
  • Diagnosis, Differential
  • Disease Progression
  • Fatal Outcome
  • Female
  • Humans
  • Lactotrophs / pathology
  • Lactotrophs / radiation effects
  • Lateral Ventricles / pathology
  • Neoplasm Invasiveness
  • Neoplasm, Residual
  • Neoplasms, Second Primary / diagnosis*
  • Neoplasms, Second Primary / etiology
  • Neoplasms, Second Primary / therapy
  • Pituitary Gland / metabolism
  • Pituitary Gland / pathology
  • Pituitary Gland / radiation effects
  • Pituitary Neoplasms / complications
  • Pituitary Neoplasms / diagnosis*
  • Pituitary Neoplasms / therapy
  • Prolactinoma / complications
  • Prolactinoma / diagnosis*
  • Prolactinoma / therapy
  • Radiotherapy / adverse effects*
  • Time
  • Time Factors

Substances

  • Biomarkers, Tumor